Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

KIDS vs BBNX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KIDS Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 6–2 Matrix Metrics)

KIDS Overall Winner 6-Pillar Tally: KIDS 6 – 0 BBNX Matrix Metrics: KIDS 6 – 2 BBNX

As of Nov 19, 2026, OrthoPediatrics Corp. (KIDS) is the stronger overall head-to-head candidate over Beta Bionics, Inc. (BBNX) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KIDS carries a Unified Composite Score of 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin), whereas BBNX carries 42.1/100 (HOLD) at $13.32 (N/M Forward P/E, -72.8% operating margin).

  • Technical & Structure Timing Caution: KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2); meanwhile BBNX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KIDS vs BBNX
KIDS NASDAQ Head-to-Head Winner
OrthoPediatrics Corp. Common Stock
Surgical & Medical Instruments & Apparatus
$32.51
+2.72% 1D
Market Cap $850.2M
TTM Revenue $264M
Forward P/E N/M
Beta / 30D Vol 0.81β · 108% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 28.0 Fund 40.0 Flow 50.0 Mom 46.3
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (12.1% over 20 days), RSI 64
RSI-14: 64.2 · SMA20: $30.90 · SMA50: $25.86
BBNX NASDAQ
Beta Bionics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$13.32
-7.05% 1D
Market Cap $779.1M
TTM Revenue $127M
Forward P/E N/M
Beta / 30D Vol 1.90β · 107% Vol
Unified Composite Score
42.1 / 100 HOLD
Tech 33.0 Fund 55.0 Flow 69.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.8%), weak momentum, RSI 35
RSI-14: 34.9 · SMA20: $16.71 · SMA50: $18.17

6-Pillar Scorecard Institutional Category Breakdown (KIDS 6 – 0 BBNX)

Columns: Metric · KIDS · BBNX
1. Valuation Multiples KIDS
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 3.2x 5.5x
2. Growth & Scale KIDS
Revenue Growth (YoY) +18.6% +30.3%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $264M $127M
Market Cap $850.2M $779.1M
3. Profitability & Quality KIDS
Gross Margin 73.8% 58.6%
Operating Margin -8.2% -72.8%
Net Profit Margin -12.8% -65.3%
Return on Equity (ROE) -9.8% -23.9%
4. Balance Sheet & Cash Flow KIDS
Cash Generation (TTM) $1.1M EBITDA -$66M
Cash Flow Margin 0.4% EBITDA Mgn -51.8%
Net Cash / Leverage $12.99 Book/Sh · -9.8% ROE $75M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning KIDS
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 145.1% (100th %ile) 531.2% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat KIDS
OpEx & R&D Intensity 82.0% of Rev ($217M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KIDS (6) vs BBNX (2)
Institutional Metric KIDS BBNX Criterion Row Edge
Market Capitalization
Scale
$850.2M $779.1M Larger Scale KIDS
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+18.6% +30.3% Higher Growth BBNX
Operating Margin (TTM)
Profitability
-8.2% -72.8% Higher Margin KIDS
Net Profit Margin
Profitability
-12.8% -65.3% Higher Margin KIDS
Return on Equity (ROE)
Capital Efficiency
-9.8% -23.9% Higher ROE KIDS
52-Week Range Position
Momentum
90% ($14–$35) 19% ($9–$33) Stronger Trend KIDS
Beta / 30D Volatility
Risk Regime
0.81β · 108% Vol 1.90β · 107% Vol Lower Realized Risk BBNX
Unified Institutional Score
Composite Signal
45.1 / 100 (HOLD) 42.1 / 100 (HOLD) Higher Composite KIDS
Trailing 12M Revenue (USD)
Operating Scale
$264M $127M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
73.8% 58.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.2x EV/Rev N/M PEG · 5.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.1M EBITDA ($12.99 Book/Sh · -9.8% ROE) -$66M ($75M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KIDS +63.98 pp
KIDS: +36.37% · BBNX: -27.61%
3M Horizon KIDS +56.82 pp
KIDS: +26.74% · BBNX: -30.08%
6M Horizon KIDS +50.86 pp
KIDS: +76.4% · BBNX: +25.54%
1Y Horizon KIDS +149.71 pp
KIDS: +98.84% · BBNX: -50.87%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KIDS vs BBNX. Trailing 12-month operating profitability (KIDS -8.2% vs BBNX -72.8%) and valuation multiples (KIDS N/M vs BBNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

KIDS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$264M
Gross Margin73.8%
Op. Margin-8.2%
ROE / Fwd P/E-9.8% · N/M
BBNX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$127M
Gross Margin58.6%
Op. Margin-72.8%
ROE / Fwd P/E-23.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KIDS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 145.1%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KIDS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BBNX BREAKDOWN
87d in phase · OBV DISTRIBUTION
Current IV 531.2%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact BBNX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KIDS Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $850.2M market capitalization and -8.2% operating margin.
OpEx & R&D Reinvestment 82.0% of Rev ($217M)
90D Engineering Disclosures 0 Published
BBNX Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $779.1M market capitalization and -72.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ KIDS vs BBNX Key Questions & Quantitative Answers

As of Nov 19, 2026, OrthoPediatrics Corp. (KIDS) is the stronger overall head-to-head candidate over Beta Bionics, Inc. (BBNX) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KIDS carries a Unified Composite Score of 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin), whereas BBNX carries 42.1/100 (HOLD) at $13.32 (N/M Forward P/E, -72.8% operating margin). Technical & Structure Timing Caution: KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2); meanwhile BBNX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KIDS leads the Growth & Scale pillar: KIDS posts +18.6% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (73.8% gross margin, -8.2% operating margin), compared with BBNX at +30.3% YoY revenue growth and +0.0% YoY earnings growth on $127M TTM revenue (58.6% gross margin, -72.8% operating margin). On trailing 12-month operating scale, KIDS generates $264M in USD-normalized revenue versus $127M for BBNX. In operating R&D and SG&A reinvestment, KIDS deploys 82.0% of Rev ($217M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BBNX.

KIDS screens cheaper on headline valuation multiples. KIDS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (0.4% EBITDA margin), whereas BBNX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 5.5x EV/Revenue (-51.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KIDS (-9.8% ROE) versus BBNX (-23.9% ROE) capital efficiency.

In options market volatility and institutional positioning, KIDS carries 145.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 108% Vol realized risk). By comparison, BBNX carries 531.2% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.90β · 107% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.